€57.90
0.17% today
Xetra, Feb 05, 05:35 pm CET
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Carl Zeiss Meditec Target price 2025 - Analyst rating & recommendation

Carl Zeiss Meditec Classifications & Recommendation:

Buy
35%
Hold
53%
Sell
12%

Carl Zeiss Meditec Price Target

Target Price €58.84
Price €57.90
Potential
Number of Estimates 16
16 Analysts have issued a price target Carl Zeiss Meditec 2026 . The average Carl Zeiss Meditec target price is €58.84. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 6 Analysts recommend Carl Zeiss Meditec to buy, 9 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2026 of . Most analysts recommend the Carl Zeiss Meditec stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Sep '24 2025
Estimates
Revenue Billion € 2.07 2.19
1.11% 6.06%
EBITDA Margin 17.59% 17.92%
15.88% 1.86%
Net Margin 8.52% 6.94%
37.46% 18.51%

16 Analysts have issued a sales forecast Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec sales estimate is

€2.2b
Unlock
. This is
6.06% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€2.3b 9.92%
Unlock
, the lowest is
€2.1b 1.92%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €2.1b 1.11%
2025
€2.2b 6.06%
Unlock
2026
€2.3b 7.23%
Unlock
2027
€2.5b 7.88%
Unlock
2028
€2.6b 4.21%
Unlock
2029
€2.8b 7.24%
Unlock

16 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2025. The average Carl Zeiss Meditec EBITDA estimate is

€393m
Unlock
. This is
8.01% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€460m 26.61%
Unlock
, the lowest is
€335m 7.92%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €364m 16.82%
2025
€393m 8.01%
Unlock
2026
€451m 14.98%
Unlock
2027
€515m 14.06%
Unlock
2028
€564m 9.53%
Unlock
2029
€592m 4.95%
Unlock

EBITDA Margin

2024 17.59% 15.88%
2025
17.92% 1.86%
Unlock
2026
19.21% 7.20%
Unlock
2027
20.31% 5.73%
Unlock
2028
21.35% 5.12%
Unlock
2029
20.89% 2.15%
Unlock

12 Carl Zeiss Meditec Analysts have issued a net profit forecast 2025. The average Carl Zeiss Meditec net profit estimate is

€152m
Unlock
. This is
13.59% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€178m 1.10%
Unlock
, the lowest is
€116m 34.33%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €176m 38.15%
2025
€152m 13.59%
Unlock
2026
€202m 32.68%
Unlock
2027
€246m 21.77%
Unlock
2028
€295m 20.10%
Unlock
2029
€345m 16.91%
Unlock

Net Margin

2024 8.52% 37.46%
2025
6.94% 18.51%
Unlock
2026
8.58% 23.63%
Unlock
2027
9.69% 12.94%
Unlock
2028
11.17% 15.27%
Unlock
2029
12.17% 8.95%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Sep '24 2025
Estimates
Earnings Per Share 2.01 1.74
38.15% 13.43%
P/E 33.28
EV/Sales 2.59

12 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€1.74
Unlock
. This is
13.43% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€2.03 1.00%
Unlock
, the lowest is
€1.32 34.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €2.01 38.15%
2025
€1.74 13.43%
Unlock
2026
€2.30 32.18%
Unlock
2027
€2.81 22.17%
Unlock
2028
€3.37 19.93%
Unlock
2029
€3.94 16.91%
Unlock

P/E ratio

Current 28.73 8.42%
2025
33.28 15.84%
Unlock
2026
25.08 24.64%
Unlock
2027
20.60 17.86%
Unlock
2028
17.15 16.75%
Unlock
2029
14.67 14.46%
Unlock

Based on analysts' sales estimates for 2025, the Carl Zeiss Meditec stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.75 38.75%
2025
2.59 5.69%
Unlock
2026
2.42 6.74%
Unlock
2027
2.24 7.31%
Unlock
2028
2.15 4.04%
Unlock
2029
2.01 6.75%
Unlock

P/S ratio

Current 2.45 43.84%
2025
2.31 5.71%
Unlock
2026
2.15 6.75%
Unlock
2027
2.00 7.31%
Unlock
2028
1.92 4.04%
Unlock
2029
1.79 6.75%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today